Detalhe da pesquisa
1.
A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia.
Br J Haematol
; 204(5): 1825-1829, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38286472
2.
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
Anticancer Drugs
; 35(1): 63-69, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067996
3.
The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers.
Cancer Med
; 12(18): 19013-19020, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587868
4.
Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis.
Blood Cancer J
; 12(4): 66, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440072